Fibrogen to host part i of virtual kol investor event series to review pamrevlumab clinical program in pancreatic cancer on february 13, 2024

San francisco, feb. 05, 2024 (globe newswire) -- fibrogen, inc. (nasdaq: fgen) today announced it will host part i of a virtual kol investor event series on tuesday, february 13, 2024 at 10:30 am et. to register, click here .

FGEN Ratings Summary

FGEN Quant Ranking